ImmPACT Bio USA Inc. is a cell therapy company aiming to develop potent and selective engineered T-cells for the treatment of solid tumors. The company was founded based on the research of Prof. Gideon Gross of the Migal Research Institute and has been incubated in the FutuRx incubator since 2017.
Market
Solid Tumors
Location
Camarillo,
CA,
USA
Coinvestors
Bukwang Pharmaceutical, Hayan Health Networks, Johnson & Johnson Development Corporation (JJDC), JVC Investment Partners, Novartis, OrbiMed Advisors, RM Global Partners, Takeda Ventures